| 000 | 01843 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515165425.0 | ||
| 264 | 0 | _c20090612 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.108.546325 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeseguer, Elena | |
| 245 | 0 | 0 |
_aOutcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. _h[electronic resource] |
| 260 |
_bStroke _cJun 2009 |
||
| 300 |
_a2104-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMazighi, Mikael | |
| 700 | 1 | _aLabreuche, Julien | |
| 700 | 1 | _aArnaiz, Carlos | |
| 700 | 1 | _aCabrejo, Lucie | |
| 700 | 1 | _aSlaoui, Tarik | |
| 700 | 1 | _aGuidoux, Celine | |
| 700 | 1 | _aOlivot, Jean-Marc | |
| 700 | 1 | _aAbboud, Halim | |
| 700 | 1 | _aLapergue, Bertrand | |
| 700 | 1 | _aRaphaeli, Guy | |
| 700 | 1 | _aKlein, Isabelle F | |
| 700 | 1 | _aLavallée, Philippa C | |
| 700 | 1 | _aAmarenco, Pierre | |
| 773 | 0 |
_tStroke _gvol. 40 _gno. 6 _gp. 2104-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.108.546325 _zAvailable from publisher's website |
| 999 |
_c18804223 _d18804223 |
||